News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
New therapeutic option for patients whose disease has progressed on or after chemotherapy treatment – LUNGevity Foundation
lungevity.org
Jul 9, 2025, 07:30

New therapeutic option for patients whose disease has progressed on or after chemotherapy treatment – LUNGevity Foundation

LUNGevity Foundation shared a post on LinkedIn:

“FDA approval alert!

On July 2, 2025 the US FDA granted accelerated approval to sunvozertinib for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

This offers a new therapeutic option for patients whose disease has progressed on or after chemotherapy treatment. Learn more here.”

cancer LUNGevity Foundation NSCLC OncoDaily Oncology US FDA
Special Coverage
Blog
Jul 11, 2025, 07:19
"Avoidable Deaths" - Union for International Cancer Control
Societies
Jul 11, 2025, 07:08
Evolving Role of Palliative Care in Treating Blood Cancers - American Cancer Society
Blog
Jul 11, 2025, 06:52
Yan Leyfman: Key Trends Across Colorectal, Gastric, Pancreatic, and Rare GI Cancers
Societies
Jul 11, 2025, 06:01
New SIOP Webinar Recording Available
Oncolibrary
Jul 11, 2025, 00:41
Hormonal Replacement Therapy in Cancer Survivors: Safety, Benefits, and Clinical Guidelines
Blog
Jul 10, 2025, 21:33
Today Marks the Beginning of Module 1 of the 2nd SIOP Europe Course in Paediatric Oncology
Blog
Jul 10, 2025, 21:24
At AACR25, Douglas Hanahan Showed That IL-1 Family Signaling Drives Systemic Immunosuppression in HPV Cancers
Blog
Jul 10, 2025, 21:13
Raelyn Was Just 4 Years Old When She Was Diagnosed With T-Cell Acute Lymphoblastic Leukemia - St. Baldrick's Foundation
Blog
Jul 10, 2025, 20:58
Janna Sisakyan: I Am Excited to Carry These Lessons Forward in My Future Medical Career
Blog
Jul 10, 2025, 20:44
We’re Excited to Announce That the First Patient Has Been Randomised in the PROLoNG Study - EORTC
Blog
Jul 10, 2025, 20:32
Paolo Tarantino: Incredibly Excited to Co-Chair the NRG Oncology Summer Symposium 2025
Blog
Jul 10, 2025, 20:21
Joshua Brody: Crystal-Clear Update on Treating Aggressive Lymphomas